Search

everythinglearnresearchcommunity

for

Search:↓

The combination of gemcitabine and vinorelbine is effective and safe for treating elderly patients with advanced breast cancer previously treated with anthracyclines and taxanes.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.

Topical tofacitinib cream may help treat certain hair loss conditions with fewer risks.

A man developed alopecia areata after starting cancer treatment with vandetanib.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Licorice component glycyrrhizic acid may reduce skin side effects from cancer treatment.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Reducing gefitinib dosage improved hair loss, but scarring remained.

Topical calcitriol may reduce hair loss from chemotherapy at higher doses.

Tofacitinib effectively treats severe alopecia areata, improving hair regrowth and patient satisfaction.

Janus kinase inhibitors can regrow hair in alopecia areata but may cause side effects and hair loss may return if treatment stops.

Gefitinib can cause hair loss without scarring.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

JAK inhibitors like tofacitinib may effectively treat alopecia in children without major side effects.

Rituximab can cause skin issues, but baricitinib may help improve them.

Tofacitinib may help treat Lichen Planopilaris, but more research is needed.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Baricitinib for severe alopecia areata is generally safe, with common side effects like infections and acne, and low rates of serious complications.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Tofacitinib helped regrow hair in people with severe alopecia, but side effects occurred and benefits stopped after treatment ended.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Baricitinib is effective and safe for treating alopecia areata.

The new drug delivery system effectively targets lung cancer cells.